FIM
CRL icon

Foresters Investment Management’s Charles River Laboratories CRL Stock Holding History

Foresters Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$23.1M Sell
174,650
-29,850
-15% -$4M 0.46% 67
2019
Q2 		$29M Sell
204,500
-7,450
-4% -$1.01M 0.52% 57
2019
Q1 		$30.8M Buy
211,950
+31,150
+17% +$4.09M 0.54% 60
2018
Q4 		$20.5M Buy
180,800
+23,200
+15% +$2.9M 0.39% 84
2018
Q3 		$21.2M Sell
157,600
-2,900
-2% -$358K 0.34% 100
2018
Q2 		$18M Buy
160,500
+7,900
+5% +$854K 0.31% 119
2018
Q1 		$16.3M Buy
152,600
+1,100
+0.7% +$119K 0.27% 134
2017
Q4 		$16.6M Sell
151,500
-13,400
-8% -$1.46M 0.26% 137
2017
Q3 		$17.8M Buy
164,900
+1,100
+0.7% +$113K 0.29% 131
2017
Q2 		$16.6M Buy
163,800
+2,800
+2% +$258K 0.28% 130
2017
Q1 		$14.5M Buy
161,000
+200
+0.1% +$17K 0.25% 145
2016
Q4 		$12.2M Buy
160,800
+31,100
+24% +$2.36M 0.22% 153
2016
Q3 		$10.8M Buy
129,700
+1,000
+0.8% +$83.8K 0.2% 153
2016
Q2 		$10.6M Buy
128,700
+7,400
+6% +$610K 0.2% 149
2016
Q1 		$9.21M Buy
+121,300
New +$8.98M 0.19% 149

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Foresters Investment Management's CRL Position: Q3 2019 in Review

Foresters Investment Management reduced its Charles River Laboratories (CRL) stake by 15% in Q3 2019, selling an estimated $4M and leaving 174,650 shares worth $23.1M. The position accounts for 0.46% of the portfolio, ranked #67.

Foresters Investment Management first reported a position in CRL in Q1 2016 and has held it in 15 quarters since. The position peaked at $30.8M in Q1 2019. 396 funds tracked by Wall St. Rank hold CRL as of Q3 2019.

  • Foresters Investment Management held 174,650 shares of Charles River Laboratories worth $23.1M as of Q3 2019.
  • Foresters Investment Management sold 29,850 Charles River Laboratories shares in Q3 2019, an estimated $4M.
  • Charles River Laboratories made up 0.46% of Foresters Investment Management's portfolio in Q3 2019, its #67 holding.
  • Foresters Investment Management first reported a position in Charles River Laboratories in Q1 2016 and has held it in 15 quarters since.
  • Foresters Investment Management's Charles River Laboratories position peaked at $30.8M in Q1 2019.
  • 396 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2019.

Based on Foresters Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.